Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.
Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, Stewart C, Fereday S, Caldas C, Defazio A, Bowtell D, Brenton JD. · 2010
Read Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. by Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, Stewart C, Fereday S, Caldas C, Defazio A, Bowtell D, Brenton JD. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3262968.txt.
Description
Ashour Ahmed and colleagues measured how universal TP53 mutations are in the most important form of ovarian cancer, in this 2010 study in the Journal of Pathology. Earlier estimates were muddied by mixed patient groups and inconsistent methods. The team sequenced the gene thoroughly in tumor DNA from a carefully defined set of patients with high-grade serous carcinoma.
Pathogenic mutations appeared in almost every confirmed case, well over nine in ten. Reviewing the few mutation-negative samples changed the picture. They showed either hidden p53 failure, through overactive partner proteins, or samples that were not truly this cancer type. The rate of p53 dysfunction thus approached one hundred percent. Mutation status did not predict survival. The authors conclude that a broken TP53 is a founding driver of this cancer, present too uniformly to serve as a prognostic marker.
Catalog record
| CREATOR | Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, Stewart C, Fereday S, Caldas C, Defazio A, Bowtell D, Brenton JD. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |